Navigation Links
FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi
Date:2/9/2011

ALEXANDRIA, Va., Feb. 9, 2011 /PRNewswire-USNewswire/ -- With generous funding totaling more than $220,000 FHSSA and the African Palliative Care Association are partnering to improve pain management among palliative care patients receiving care in hospitals in The Gambia, Kenya, and Malawi.

These three countries were selected because they each have well-established national palliative care organizations, strong clinical leadership, historical success with related projects, and sound professional relationships with APCA and FHSSA staff/leadership.

FHSSA's executive director, John Mastrojohn, traveled to Uganda this week to participate in kick-off meetings for the project.

FHSSA and APCA identified a set of challenges for the management of pain in The Gambia, Kenya, and Malawi. Hospital-based health care workers sometimes have a limited understanding of the palliative care concept and the need for palliative care services.

"Often, physicians are not comfortable in effectively prescribing opioids, such as morphine. This can be due to lack of skills in pain assessment and management, coupled with fears around the use of these powerful medications," said Mastrojohn.

The project framework is based on the success of a pilot project in Uganda that was endorsed by the World Health Organization and the Ugandan Ministry of Health. Objectives include:

  1. To create awareness of, support for and prioritization of palliative care delivery among hospital management/administrators.
  2. To train hospital physicians in pain assessment and management, with a central focus on opioid use.
  3. To sensitize other health care workers in the hospitals and community to support palliative care service delivery.

Funding was provided by Astellas Pharma US, Inc. , AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Inc., Endo Pharmaceuticals Inc., Lundbeck Inc, OSI Pharmaceuticals Inc., Pharmaceutical Research and Manufacturers of America (PhRMA), Grunenthal, and The Brin Wojcicki Foundation.

Learn more about the work of FHSSA at www.fhssa.org.

The Winter issue of FHSSA's "Focus on Compassion" newsletter is available online at http://www.fhssa.org/files/public/Quarterly/Focus_Winter_2011.pdf. Contact:Susan MessinaDirector of Communications and Special EventsOffice of Philanthropy (National Hospice Foundation and FHSSA)571-275-4324smessina@nationalhospicefoundation.org
'/>"/>

SOURCE FHSSA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
2. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
3. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
8. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
9. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
10. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
11. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... 4, 2016 Wegener Polyangiitis - Pipeline ... Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 2015, ... pipeline. This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ...
(Date:2/4/2016)... 2016 Summary Breast cancer, a malignant ... most common cancer in women worldwide, accounting for 16% ... The number of women diagnosed with breast cancer has ... of deaths has declined due to earlier diagnosis and ... revolutionized in the past four decades, especially with increasing ...
Breaking Medicine Technology:
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... Shark ... to announce the launch of a new DRTV campaign with Belly Bands. , Having ... tried everything from sprays to puppy pads and find nothing works, get Belly ...
(Date:2/5/2016)... ... ... Love is in the air at King Kullen! The local grocer is ... staple for Valentine’s Day is a must-have, and can be picked up with all ... are long-stem roses available, but also other flower bouquets, elegantly wrapped and ready to ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... and setting the stage for new clinical and scientific initiatives have all marked ... after she was appointed President and CEO of the nation’s oldest cancer center, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco ... micro-needling services in their Napa Valley office. The technique utilizes the body’s own ... Dr. Canales and Dr. Furnas, are part of only a select few cosmetic ...
(Date:2/5/2016)... ... ... After years as an active staff surgeon and having served as the director ... transitioned to chief of the Division of Plastic Surgery at what is now known ... began a second three-year term in January of 2016. , The original selection was ...
Breaking Medicine News(10 mins):